A Study to Evaluate the Safety and Efficacy of XC221 in Patients With Uncomplicated Influenza or Other Acute Viral Upper Respiratory Infections

NCT05544916 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

260

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza
Respiratory Viral Infection

Interventions

DRUG: XC221
DRUG: Placebo

Sponsor

Valenta Pharm JSC